REAP Financial Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
REAP Financial Group's BTAL Position: Q2 2026 in Review
REAP Financial Group reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 13% in Q2 2026, selling an estimated $27.2K and leaving 14,559 shares worth $162K. The position accounts for 0.03% of the portfolio, ranked #159.
REAP Financial Group first reported a position in BTAL in Q4 2023 and has held it in 11 quarters since. The position peaked at $634K in Q1 2024. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- REAP Financial Group held 14,559 shares of AGF US Market Neutral Anti-Beta Fund worth $162K as of Q2 2026.
- REAP Financial Group sold 2,238 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $27.2K.
- AGF US Market Neutral Anti-Beta Fund made up 0.03% of REAP Financial Group's portfolio in Q2 2026, its #159 holding.
- REAP Financial Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and has held it in 11 quarters since.
- REAP Financial Group's AGF US Market Neutral Anti-Beta Fund position peaked at $634K in Q1 2024.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.